Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
From a pharmacological safety perspective, the adverse effect profile of retatrutide based on Phase 1 and Phase 2 clinical trial data (including the NEJM 2023 Phase 2 trial) includes: Gastrointestinal effects: Nausea, vomiting, diarrhoea, and constipation (the most commonly reported side effects in trial participants) Injection site reactions: Redness, swelling, or discomfort at the injection site Cardiovascular effects: Increases in heart rate have been observed in trial participants [21] [22] Hypoglycaemia: Particularly relevant in individuals with diabetes or those taking insulin, sulfonylureas, or other glucose-lowering agents Potential thyroid effects: GLP-1 receptor agonists have been associated with thyroid C-cell changes in rodent studies
Other reported effects Beyond GI symptoms, clinical trial data reported several other effects worth noting for research protocol design
Ultimate Solutions Medical Spa serves patients throughout Stamford with the latest in metabolic medicine
Does 5-amino-1mq have a finalized analytical record
US$ 26.80
US$ 29.52
US$ 27.68
US$ 26.00
